Skip to main content
UCL Ventures Navigate back to homepage
Find your Business Manager

Main navigation

  • Your route to market

    Your route to market

    We guide UCL academics, researchers and clinicians to get their research to market.

    Disclose an idea
    • Getting started An introduction to commercialisation and next steps
    • Our collaborative approach How we work with you to get to market
    • What you can expect Demystifying the process of commercialisation
    • Options to move forwards Explore the different pathways to market
      • Protect your idea
      • Create a company
      • Licensing your invention
      • Routes to social impact
    • Funding & support The financial and practical help that we can offer
      • Help managing your project
      • Training & tools
      • Common questions
  • Explore innovations

    Explore innovations

    Our portfolio and technologies span AI and quantum, to gene therapies to consumer products.

    • Spinout portfolio Browse our portfolio of spinout companies, based on UCL research
    • Our expertise & pipeline The sectors we span and therapeutics in development
    • Social Ventures Ventures driving impact in communities
    • License a technology Opportunities & collaborations with UCL's world-class research
  • Global impact

    Global impact

    How UCL research is changing the way the world lives, works and thrives.

    • Inspiring stories Real-world impact and successes, supported by UCL Ventures
    • Impact Report Our annual report showcases how UCL research is going beyond the university
    • Supporting innovation at UCL Understand our role in the innovation ecosystem
  • Investors & business

    Investors & business

    Opportunities for collaboration across UCL's world-class research.

    • Why partner with UCL Ventures With over 30 years in commercialisation, we have a strong track record
    • Our portfolio View our spinout companies across all sectors
  • News & events

    News & events

    The latest news and events from our team and portfolio.

    • News & views Stay up to date with the latest insights and announcements
    • Events Where you can find us across UCL and external events
  • Get in touch

    Get in touch

    Contact our team of experts for all your queries and needs.

    • Speak to the team Choose your enquiry type to reach the right team
Find your Business Manager

Breadcrumb trail

  1. Home
  2. Events programme
  3. [Past] Transforming the success of keyhole surgery with AI-enhanced imaging

Event attendance:

In person

Date & time:

7 October 2026, 17:30 - 7 October 2026, 19:30

Location:

Housman Room, UCL

[Past] Transforming the success of keyhole surgery with AI-enhanced imaging

A Housman Talk by Dr Maria Leiloglou, CEO of Enacuity

Dr Maria Leiloglou in front of Enacuity's hyperspectral imaging

This event is in the past.  If you would like more information including on the technology and Enacuity, please contact events@uclventures.com

AI-powered surgical imaging is opening up new possibilities for safer, more effective minimally invasive surgery. Dr Maria Leiloglou, founder and CEO of Enacuity, will share the story behind the UCL and Imperial spinout’s journey from research insight to commercial venture.  

The aim of the Housman talks is to promote collegiality, encourage interdisciplinary relations and introduce new ASCR members to other users of the Housman Room. 

By invitation and only open to ASCR members.

Our team attending

Marina Santilli

Interim Director of Physical Sciences & Engineering

Marina has specialised in the commercialisation of computer science and AI-based inventions and deep tech venture building since joining UCL Ventures in 2007. She headed straight into industry after graduating in Physics from Imperial College, enjoying a successful career in datacomms engineering and becoming Director of new product development at Verizon.

In 2010 she designed and developed E-lucid, a platform to enable online licensing of UCL’s intellectual property. E-lucid is now used by over 30 research institutions around the world and was spun out as a commercial business in 2023.

Marina was involved in the formation of many successful UCL spinouts including Satalia, Re:infer, 3DRepo, MatrixMill, Humanloop, Stanhope AI.

Dr Weng Sie Wong

Senior Business Manager

Dr Wong brings extensive experience of all aspects of university technology transfer activities from strategic IP management to licence negotiations and spinout formation.

As a Senior Business
Manager focusing on the commercialisation of medical technologies, healthcare engineering, medical imaging and AI-enabled healthcare innovations arising from UCL research, she has been involved in the formation of multiple spinouts and acted as a director on various boards.

Prior to joining UCL Ventures, Dr Wong was a senior technology transfer manager at Oxford University’s TTO, Oxford University Innovation, working on a diverse range of both life and physical science projects over a 10-year period.

Weng holds an MBA from Edinburgh University and a PhD in pharmacology from UCL.

  • LinkedIn

Dr. Barny Cox

Senior Business Manager

Dr Cox is responsible for assisting in the commercial exploitation of IP arising from UCL’s departments of Medicine, Structural and Molecular Biology, Infection and Immunity, Chemical Biology, Biochemical Engineering, Medical Physics and BioEngineering, Epidemeology and Health and Psychology and Language Sciences.

Prior to joining UCL Ventures, Barny was a technology transfer manager at Queen Mary Innovation, where in addition to acting as a director on the board and company secretariat to a Queen Mary, University of London spinout, he gained a wealth of experience in the commercialisation of a broad portfolio of healthcare and other life science-related technologies, assisting in the patent prosecution of new commercially-viable innovations, the acquisition of translational funds and successful marketing, negotiation and execution of a number of out-licensing deals.

Barny has previously held positions with the British Medical Association and two internationally-acclaimed patent and trademark firms, where he gained a thorough grounding in intellectual property prosecution.

He completed an MRC Career Development Fellowship at the National Institute for Medical Research in the field of developmental neurobiology, studying the morphogenic Sonic Hedgehog signalling cascade in mammalian neural tube cell-fate specification and holds a doctorate awarded by UCL.

Dr Adam Hajjar, Business Manager

Billy Lam, Business Manager

UCL Ventures footer

About UCL Ventures

  • Our people
  • What we do
  • Who we are
  • Our culture

Forms & Resources

  • Publications and downloads

Accreditations

  • Cyber essentials
    cyber essentials logo
  • Living wage
    living wage employer logo
UCL Ventures

UCL Ventures Limited (Company Registration No: 02776963) is a wholly-owned subsidiary of University College London. 

Registered office: 
University College London
Gower Street
London
WC1E 6BT

UCL social media menu

  • Link to Linkedin
Back to top

Legal

  • Cookie policy
  • Freedom of information
  • Privacy policy
  • Rules of website use

© 2026 UCL Ventures Limited